L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)
NCT ID: NCT01330823
Last Updated: 2011-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
PHASE3
72 participants
INTERVENTIONAL
2006-06-30
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developmental Study on Fatigue in Cancer
NCT00034450
Levocarnitine in Treating Fatigue in Cancer Patients
NCT00091169
Enteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung Cancer
NCT07035444
L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer
NCT00754767
The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients
NCT01025167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study drug: L-Carnitine 4g per day (vers) Placebo Study design: A multi-centre, double blind, and placebo-controlled, randomised, parallel group study
Patient population: Patients with advanced pancreatic carcinoma Number of patients: Total of 90 patients in two equal groups number of centres: 4 (Greifswald, Magdeburg, Berlin,Heidelberg,all Germany) Duration of dosing: 12 weeks
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L-Carnitine
L-Carnitine 4 g daily for Intervention
L-Carnitine
L-Carnitine, 4g/day, orally (Juice)
Placebo
Placebo (tartaric acid)
Placebo
tartaric acid same dose like L-Carnitine as placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-Carnitine
L-Carnitine, 4g/day, orally (Juice)
Placebo
tartaric acid same dose like L-Carnitine as placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Karnofsky Index larger than 60
* compliance
* consent to participate to the study
Exclusion Criteria
* a known second malignant tumor
* oral or parenteral supplementation with omega-3-fatty acids
* treatment with thalidomide or Infliximab
* mental or physical disorders
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medicine Greifswald
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Medicine A
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Markus M. Lerch, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Medicine Greifswald
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medicine Greifswald,Department of Medicine A
Greifswald, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CARPAN-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.